MIRM peer analysis
Mirum Pharmaceuticals (MIRM) against its competitors: price, today's move, 1-year return and market value side by side.
MIRM and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| AGIO Agios Pharmaceuticals | $29.95 | -1.96% | -30.64% | $1.82B |
| ALT Altimmune | $2.04 | -4.67% | -49.88% | $396.82M |
| ARCT Arcturus | $11.03 | -9.22% | 14.54% | $313.51M |
| ENTA Enanta Pharmaceuticals | $10.71 | -3.95% | -1.38% | $311.93M |
| MDGL Madrigal Pharma | $430.59 | 0.05% | 0.72% | $9.94B |
| RARE Ultragenyx | $16.32 | 1.37% | -53.60% | $1.59B |
| TVTX Travere Therapeutics | $47.30 | -6.13% | 59.53% | – |
| MIRM Mirum Pharmaceuticals | $85.82 | 0.96% | 18.86% | $5.52B |
- MIRM's peers: AGIO (Agios Pharmaceuticals), ALT (Altimmune), ARCT (Arcturus), ENTA (Enanta Pharmaceuticals), MDGL (Madrigal Pharma), RARE (Ultragenyx), TVTX (Travere Therapeutics).
Updated 2026-11-03 02:02 UTC